Connection
Jed Lampe to Antiviral Agents
This is a "connection" page, showing publications Jed Lampe has written about Antiviral Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.384 |
|
|
|
-
Pentyala A, Kandel SE, Lampe JN. Mechanistic insights into human carboxylesterase 2 (CES2) inhibition by the CES1 prodrug substrate remdesivir. Drug Metab Dispos. 2025 Oct; 53(10):100158.
Score: 0.601
-
Work HM, Hackett JC, Lampe JN. HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation. Drug Metab Dispos. 2024 05 16; 52(6):516-525.
Score: 0.549
-
Hicks EG, Kandel SE, Lampe JN. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors. Bioorg Med Chem Lett. 2022 06 15; 66:128732.
Score: 0.119
-
Work HM, Kandel SE, Lampe JN. Characterization of fluorescent probe substrates to develop an efficient high-throughput assay for neonatal hepatic CYP3A7 inhibition screening. Sci Rep. 2021 09 30; 11(1):19443.
Score: 0.114